Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool from late 2020.
Dr Ashraf Azzabi graduated in 1992 and joined the Northern Centre for Cancer Care in 1997 as a registrar in medical oncology and completed a research degree in early drug development at Newcastle University. He treats testicular, urological and colorectal cancers in Newcastle, Sunderland and South Tyneside.
Dr Ashraf Azzabi is actively involved, as a principal investigator, in a number of national and international clinical trials both in urological and colorectal cancers. He chaired the systemic therapies group at the cancer centre, the north east of England colorectal cancer tumour specific group. He also currently leads the late phase cancer research team at the northern centre for cancer care and has a role as the NIHR cancer research lead for the Newcastle upon Tyne hospitals NHS foundation Trust and, holds a role as the regional clinical lead for cancer research at the NIHR North east and North Cumbria research network.
Northern Cancer Alliance Expert Advisory Groups
National Institute for Health Research North East and North Cumbria (NIHR NENC)
Dr Ashraf Azzabi does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Ashraf Azzabi does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Ashraf Azzabi does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or